Results 251 to 260 of about 1,318,825 (382)
Abstract Tumor‐infiltrating B cells (TIBs) exhibit dual roles in the tumor microenvironment (TME) of solid tumors. While they can enhance anti‐tumor immunity through antibody production and immune activation, certain subsets—such as regulatory B cells (Bregs) and immunosuppressive plasma cells—contribute to immune evasion by secreting inhibitory ...
Zhitong Li +5 more
wiley +1 more source
Belatacept in Pancreas Transplantation: Promising Insights From a Cohort Series. [PDF]
Masset C +10 more
europepmc +1 more source
Enteric-drained pancreas transplants monitored by fine-needle aspiration biopsy [PDF]
A. Sugitani +16 more
core +2 more sources
Kidney and Pancreas Transplantation in the United States, 1998–2007: Access for Patients with Diabetes and End-Stage Renal Disease [PDF]
Keith McCullough +5 more
openalex +1 more source
The impact of race on metabolic, graft, and patient outcomes after pancreas transplantation
Haley M. Gonzales +6 more
openalex +2 more sources
What's New? Small cell lung cancer (SCLC) is aggressive and difficult to treat but exhibits high levels of stathmin 1 (STMN1), a candidate therapeutic target. In this study, the authors synthesized a chlorambucil (Chb)‐conjugated pyrrole–imidazole polyamide (PIP) compound targeting the STMN1 promoter and DNA sequences and evaluated its efficacy in ...
Ryohei Yoshikawa +23 more
wiley +1 more source
What's New? The current standard of care for locally advanced or metastatic renal cell carcinoma (aRCC) is either a combination of two immune checkpoint inhibitors (CPI) or a CPI plus a tyrosine kinase inhibitor (TKI). Here, the authors simulate a head‐to‐head trial comparing the real‐world effectiveness of these combination therapies with TKI ...
Peter J. Goebell +15 more
wiley +1 more source

